Physician

Namrata Nandakumar, MD

According to 2025 Medicare claims, Namrata Nandakumar, MD (NPI: 1932364817) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Essex, MA. This provider's primary affiliated billing organization is JOHN J WEITER, MD, PC (NPI: 1891033411; TIN: 042731078) and primary practice location at 01960-1666. Nandakumar is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Nandakumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 694 traditional Medicare patients, billed 12,370 HCPCS/CPT codes, and received $2,728,350 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,390 prescription claims across 258 beneficiaries totaling $68,197 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 8 records totaling $172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $354,540 to $2,728,350. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $10,597 to $68,197. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $354,540 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $415,674 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $355,557 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $570,352 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $772,508 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,097,818 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,547,634 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,379,122 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,311,195 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,728,350 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154693,127$354,540
20164603,927$415,674
20174714,189$355,557
20185635,805$570,352
20194765,574$772,508
20205766,917$1,097,818
20217289,221$1,547,634
20226448,849$1,379,122
202375710,721$2,311,195
202469412,370$2,728,350

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$38K$77K2015 Drug cost: $10,597 (USD; Tot_Drug_Cst)2016 Drug cost: $16,224 (USD; Tot_Drug_Cst)2017 Drug cost: $10,206 (USD; Tot_Drug_Cst)2018 Drug cost: $27,747 (USD; Tot_Drug_Cst)2019 Drug cost: $38,393 (USD; Tot_Drug_Cst)2020 Drug cost: $59,090 (USD; Tot_Drug_Cst)2021 Drug cost: $65,342 (USD; Tot_Drug_Cst)2022 Drug cost: $77,000 (USD; Tot_Drug_Cst)2023 Drug cost: $63,520 (USD; Tot_Drug_Cst)2024 Drug cost: $68,197 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201549168$10,597
201651209$16,224
201751197$10,206
201890450$27,747
2019105508$38,393
2020157814$59,090
2021187983$65,342
20222131,135$77,000
20232271,193$63,520
20242581,390$68,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2282,138$79
92012Established patient problem focused exam of visual system4491,045$62
92014Established patient complete exam of visual system207217$60
92134Imaging of retina6302,592$28
92202Extended exam of the back part of the eye with optic nerve drawing402814$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine18600$10,178
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol241,363$6,386
CyclosporineCyclosporine14555$5,382
ProlensaBromfenac Sodium13228$4,865
Prednisolone AcetatePrednisolone Acetate1474,018$4,260

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$172Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Namrata Nandakumar, MD?

Tedicare shows public-source Medicare data for Namrata Nandakumar, MD (NPI 1932364817), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Namrata Nandakumar, MD have ACO affiliation data?

Namrata Nandakumar, MD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Namrata Nandakumar, MD?

Namrata Nandakumar, MD is linked to JOHN J WEITER, MD, PC (billing NPI 1891033411) in the available physician profile data.

Does Namrata Nandakumar, MD have Open Payments data?

Namrata Nandakumar, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.